Methodological considerations in meta-analysis of statin use as adjunctive therapy for schizophrenia: Insights and limitations

Gen Hosp Psychiatry. 2024 Sep-Oct:90:202-203. doi: 10.1016/j.genhosppsych.2024.06.014. Epub 2024 Jul 1.

Authors

Marisa Bezerra de Araújo¹, Lia Mesquita de Abreu¹, João Pedro da Silva Barbosa¹, Guilherme Nobre Nogueira¹, Fabio Gomes de Matos E Souza², Luisa Weber Bisol³

Affiliations

¹ Federal University of Ceará, Brazil.
² Federal University of Ceará, Brazil; Walter Cantídio University Hospital, Brazil.
³ Federal University of Ceará, Brazil; Walter Cantídio University Hospital, Brazil. Electronic address: [email protected].

PMID: 39068129
DOI: 10.1016/j.genhosppsych.2024.06.014

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents* / administration & dosage
Drug Therapy, Combination / methods
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / administration & dosage
Meta-Analysis as Topic
Research Design
Schizophrenia* / drug therapy

Substances

Antipsychotic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors